News Focus
News Focus
Followers 5
Posts 521
Boards Moderated 0
Alias Born 06/11/2024

Re: AMRNEPA post# 428552

Friday, 08/30/2024 12:13:59 PM

Friday, August 30, 2024 12:13:59 PM

Post# of 448124
Triple, I think the PMB loss is not as substantial as is being assumed given the 2/3 of the sales are Medicare and unaffected. I think they could quickly slash costs to print flat forward quarters. Buying back your shares at a $250m cap is a no brainer when a strategic buyer effectively gets it for free at $800m and worth much more assuming positive value for the existing patents. The value is wasted via the continued go alone strategy... the value is with a big European player with a sales force that can drive sales. They should buy back $50m to enhance current shareholder value and put it up for sale... explicitly by hiring bankers to shop it if necessary.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News